Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020.

2019 novel coronavirus disease COVID-19 SARS-CoV-2 United States coronavirus disease healthcare personnel respiratory infections risk factors severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 3 12 2021
medline: 25 12 2021
entrez: 2 12 2021
Statut: ppublish

Résumé

To determine risk factors for coronavirus disease (COVID-19) among US healthcare personnel (HCP), we conducted a case-control analysis. We collected data about activities outside the workplace and COVID-19 patient care activities from HCP with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results (cases) and from HCP with negative test results (controls) in healthcare facilities in 5 US states. We used conditional logistic regression to calculate adjusted matched odds ratios and 95% CIs for exposures. Among 345 cases and 622 controls, factors associated with risk were having close contact with persons with COVID-19 outside the workplace, having close contact with COVID-19 patients in the workplace, and assisting COVID-19 patients with activities of daily living. Protecting HCP from COVID-19 may require interventions that reduce their exposures outside the workplace and improve their ability to more safely assist COVID-19 patients with activities of daily living.

Identifiants

pubmed: 34856114
doi: 10.3201/eid2801.211803
pmc: PMC8714235
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-103

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Clin Infect Dis. 2017 Oct 15;65(8):1335-1341
pubmed: 29017249
J Assoc Physicians India. 2020 Dec;68(12):55-57
pubmed: 33247643
Infect Control Hosp Epidemiol. 2022 Jan;43(1):120-122
pubmed: 33308349
BJPsych Open. 2021 Jan 20;7(1):e40
pubmed: 33468277
Am J Epidemiol. 2002 Apr 1;155(7):593-602
pubmed: 11914186
Antimicrob Resist Infect Control. 2020 Jun 11;9(1):83
pubmed: 32527300
Clin Infect Dis. 2021 Sep 15;73(6):e1329-e1336
pubmed: 33857303
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1441-1442
pubmed: 32741406
Emergencias. 2020 Ago;32(4):227-232
pubmed: 32691999
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1053-1059
pubmed: 33292895
Anaesthesia. 2021 Feb;76(2):174-181
pubmed: 33022093
Infect Control Hosp Epidemiol. 2021 Apr;42(4):381-387
pubmed: 32900402
Ann Intern Med. 2021 May;174(5):649-654
pubmed: 33513035
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
BMJ. 2016 Feb 25;352:i969
pubmed: 26916049
Eur J Emerg Med. 2021 Jun 1;28(3):202-209
pubmed: 33105329
JAMA Netw Open. 2021 Mar 1;4(3):e211283
pubmed: 33688967
Infect Control Hosp Epidemiol. 2022 Aug;43(8):1058-1062
pubmed: 34075869
PLoS One. 2012;7(4):e35797
pubmed: 22563403
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Crit Care Med. 2021 Jul 1;49(7):1159-1168
pubmed: 33749225
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):382-388
pubmed: 33735165
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):566-569
pubmed: 33857062

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH